Numan's Vertical Integration Advantage

This model turns Numan from a lead generator into the operator that gets paid at every step of care. A patient does not just click out to a third party pharmacy after an online form. They complete intake in Numan’s app, are reviewed by Numan clinicians or prescribing pharmacists, receive medication from its own pharmacy, and stay in the same app for coach messaging, follow up, and ongoing monitoring. That means Numan keeps both service revenue and fulfillment economics, while controlling speed, packaging, and repeat care.

• The product flow is tightly bundled. Weight loss plans start at £179 per month and include GLP-1 medication, clinician support, coach messaging, and scheduled blood testing with results shown in app. That is a much larger revenue pool than a referral model that only hands off a prescription.
  1 sacra
• A useful comparison is Yazen. Yazen also sells a subscription for clinical support, but patients buy medication separately from partner pharmacies. Numan goes one step further by owning the pharmacy layer, so it can capture dispensing margin in addition to subscription revenue.
  1 sacra 4 sacra
• Owning more of the stack also matters competitively. Ro linked directly with NovoCare pharmacy for Wegovy fulfillment, and Hims agreed to acquire ZAVA to deepen its European care and pharmacy footprint. In this category, the winners are increasingly the companies that combine prescribing, fulfillment, and ongoing care in one system.
  1 sacra 5 ro 6 hims

The next phase is to reuse the same operating spine across more categories, especially women’s health and broader metabolic care. Once the app, clinical review, pharmacy, and follow up loops are in place, each new condition can plug into the same workflow, which should raise lifetime value and make Numan harder to displace with a cheaper prescription only service.